CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced ...

Key growth updates included the closing of a 10% interest acquisition in the Matterhorn Express pipeline, upsizing the Traverse Pipeline project, and sanctioning the $900 million Clear Fork project in ...

Regeneron reports strong Q2 2025 growth with Dupixent sales up 21% and EYLEA HD hitting record highs. Explore key earnings insights and pipeline updates.

Microsoft Corporation (NASDAQ:MSFT) is one of the AI Stocks Investors Should Keep an Eye On. On July 31, TD Cowen analyst ...

Cenovus is now forecasting its 2025 upstream production will be between 805,000 bpd of oil equivalent and 825,000 bpd, compared with 805,000 bpd–845,000 projected previously, because of the temporary ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, ...

Apple has reported record revenues and done so with success in three key areas, none of which required Apple Intelligence, which analysts insisted the company needed to concentrate on. Here's how the ...

The share price of Expand Energy Corporation (NASDAQ:EXE) surged by 5.58% between July 23 and July 30, 2025, putting it among the Energy Stocks that Gained the Most This Week. Formed in 2024 by the ...

Tweet; Print; Track Keywords; Bailey McCann, Opalesque New York: US oil and gas producers are facing a number of headwinds. OPEC announced last week it would release more supply o ...

During that time, revenues at C.H. Robinson and in NAST were largely flat, owing to still-weak freight markets. That is the definition of productivity increases: getting done the same amount of work ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, ...

Wall Street isn't happy with Apple's slow AI progress, but one analyst says investors need a bit more patience. TD Cowen's Krish Sankar recently wrote that he thinks Apple deserves a bit of time to ...